Literature DB >> 25394506

Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1.

Chao Gao1, Chun Han1, Qiyao Yu2, Yue Guan3, Na Li3, Jingjing Zhou3, Yanming Tian3, Yi Zhang3.   

Abstract

Musashi1 (Msi1), a member of the RNA-binding protein (RBP) family, is highly expressed in neural progenitor or stem cells for the maintenance of stemness as well as in various cancers. Emerging studies have demonstrated that it regulates cell processes by translational activation or suppresses specifically bound mRNA. In the present study, we initially reported remarkably increased expression of Msi1 in colon cancer tissues compared with adjacent non-tumor tissues. Knockdown of Msi1 significantly suppressed the proliferation, colony formation, tumorsphere formation and the progression of implanted colon cancers, and induced cell cycle attest at G0/G1 phase, along with the upregulated expression of p21(cip1). Reporter assays using a chimeric mRNA that combined luciferase and the 3'-UTR of p21(cip1) revealed that Msi1 decreased the reporter activity through the specific motif. Thus, the current results suggested that downregulation of Msi1 could inhibit the growth of colon cancers and Msi1 may be a promising therapeutic target molecule for human colon cancers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394506     DOI: 10.3892/ijo.2014.2749

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

Review 1.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

2.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 3.  Nerves in gastrointestinal cancer: from mechanism to modulations.

Authors:  Nathalie Vaes; Musa Idris; Werend Boesmans; Maria M Alves; Veerle Melotte
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

4.  Increased Musashi-2 and Decreased NUMB Protein Levels Observed in Human Colorectal Cancer are reverted to Normal Levels by ATRA-Induced Cell Differentiation.

Authors:  Lynn M Opdenaker; Ryan Kowash; Gabriel Masters; Bruce M Boman; Tao Zhang; Shirin R Modarai
Journal:  Int J Cancer Res Ther       Date:  2018-08-15

5.  miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Tumour Biol       Date:  2015-11-12

6.  Structural Insight into the Recognition of r(UAG) by Musashi-1 RBD2, and Construction of a Model of Musashi-1 RBD1-2 Bound to the Minimum Target RNA.

Authors:  Ryo Iwaoka; Takashi Nagata; Kengo Tsuda; Takao Imai; Hideyuki Okano; Naohiro Kobayashi; Masato Katahira
Journal:  Molecules       Date:  2017-07-19       Impact factor: 4.411

Review 7.  Post-transcriptional Regulation of Colorectal Cancer: A Focus on RNA-Binding Proteins.

Authors:  Jennyfer M García-Cárdenas; Santiago Guerrero; Andrés López-Cortés; Isaac Armendáriz-Castillo; Patricia Guevara-Ramírez; Andy Pérez-Villa; Verónica Yumiceba; Ana Karina Zambrano; Paola E Leone; César Paz-Y-Miño
Journal:  Front Mol Biosci       Date:  2019-08-07

Review 8.  Musashi-1-A Stemness RBP for Cancer Therapy?

Authors:  Nadine Bley; Ali Hmedat; Simon Müller; Robin Rolnik; Alexander Rausch; Marcell Lederer; Stefan Hüttelmaier
Journal:  Biology (Basel)       Date:  2021-05-05

9.  DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.

Authors:  Y M Choi; K B Kim; J H Lee; Y K Chun; I S An; S An; S Bae
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

10.  Interplay among p21Waf1/Cip1, MUSASHI-1 and Krüppel-like factor 4 in activation of Bmi1-CreER reserve intestinal stem cells after gamma radiation-induced injury.

Authors:  Emilia J Orzechowska; Takahito Katano; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.